… oral anticoagulants have recently emerged as an attractive choice for patients requiring
anticoagulation … doses without the need for routine anticoagulation monitoring. They may present …

… Dose-reduced regimens of direct oral anticoagulants (DOACs) may be used for 2 main
purposes: dose-adjusted treatment intended as full-intensity anticoagulation (eg, for stroke …

… oral anticoagulant use in patients with cirrhosis may be as safe as traditional anticoagulants.
… less major bleeding events, while maintaining efficacy at preventing stroke or thrombosis. …

… This study aims to review the published literature concerning the use of novel oral
anticoagulants (NOACs) in the treatment and prevention of venous thromboembolism (VTE) and to …

… We found that the novel oral anticoagulants significantly … The novel oral anticoagulants may
potentially address some … and a more predictable anticoagulant effect, thus allowing fixed-…

… In clinical trials new oral anticoagulants (NOAC) have proved … The aim of this study was to
evaluate the efficacy and safety … was to evaluate the efficacy and safety of treatment with NOAC …

Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …

… To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world …
Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation …

… among patients taking the novel oral anticoagulants dabigatran and rivaroxaban.1 … oral
anticoagulants for atrial fibrillation are typically older than those receiving anticoagulation for …

… Direct oral anticoagulants are contraindicated in patients with … the pharmacology of direct
oral anticoagulants, summarise the … perspectives for the development of oral anticoagulants. …